Key facts
| Price (PPV) | 2,851 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | déférasirox |
| Class | All other therapeutic products |
| ATC code | V03AC03 |
| Manufacturer | NOVARTIS PHARMA MAROC |
| Presentation | Boîte de 28 |
| Nature | Médicament |
| Hospital price | 2,523 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement des hémosidéroses post-transfusionnelles. Traitement de la surcharge en fer chronique nécessitant un traitement chélateur chez les patients à partir de 10 ans présentant une thalassémie non dépendante des transfusions. Source : Compendium.ch - Date : 20 octobre 2025
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Deferox 250 mg (NOVOPHARMA) contains the same active substance as Exjade 250 mg (Déférasirox) at the same strength, but in a different pack: Boite de 30 at 1,446 MAD, i.e. 48.20 MAD per unit against 101.82 MAD for Exjade 250 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Deferox 250 mg | NOVOPHARMA | Boite de 30 | 1,446 MAD | 48.20 / unit |
| Zorifort 250 mg | PROMOPHARM (HIKMA) | Boite de 30 | 1,613 MAD | 53.77 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Exjade 250 mg
Exjade 250 mg belongs to the all other therapeutic products therapeutic class. In Morocco, this drug is marketed by NOVARTIS PHARMA MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Exjade 250 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Exjade 250 mg
Answers to common questions from Moroccan patients about this drug.